38228 Car-t admn autologous
Also known as: CAR-T infusion, CAR-T administration
Infusion of autologous chimeric antigen receptor T-cells into the patient for therapeutic treatment of hematologic malignancy.
In Plain Language
Infusing engineered immune cells
Clinical Context
Therapeutic infusion of patient's own engineered CAR-T cells for treatment of leukemias and lymphomas.
RVU Breakdown
| Work RVU | 3.00 |
| Total RVU | 3.00 |
Est. Medicare Payment
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Billing & Documentation
As a surgical CPT code, proper documentation must include the operative report detailing the procedure performed, patient positioning, approach, findings, and any complications. Ensure the diagnosis code (ICD-10) supports medical necessity for the procedure.
How This Code Compares
With a work RVU of 3.00, this code ranks in the 21st percentile among Surgery codes — 2.7x below the median (8.00). The highest wRVU in this category is 106.19.
Specialties
Frequently Asked Questions
What is CPT code 38228?
CPT 38228 (Car-t admn autologous) is a Surgery code. Infusion of autologous chimeric antigen receptor T-cells into the patient for therapeutic treatment of hematologic malignancy.
What is the wRVU value for CPT 38228?
The work RVU for CPT 38228 is 3.00. This code is primarily used by Hematology/Oncology, Immunotherapy, Infusion Medicine.
When is CPT 38228 used?
Therapeutic infusion of patient's own engineered CAR-T cells for treatment of leukemias and lymphomas.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.